YOU! Yes - you over there who might be regarded as being "older".
It is YOUR fault!
THEY want to remove your thyroid hormone prescription. Just because you are older.
But THEY are having problems doing that and the problems are:
❗️patients' perceived need for thyroid hormone use
Your actual need is immaterial. It is your perception of your need that gets in the way.
❗️patient anxiety/concerns about potential side effects related to thyroid hormone dose reduction
You are not allowed to be anxious or have concerns about losing your thyroid hormone prescription.
❗️patient lack of knowledge, and misinformation regarding deprescribing
You are ignorant. You are misinformed about deprescribing. (And just who is doing ANY informing about deprescribing - other than medics and a few of us here?
❗️patients' trust in their treating physician
You absolutely MUST trust your physician. No matter any history with that person - or complete lack of any history.
OK - they do mention some physician issues.
Yes. I am absolutely angry.
Of course people - older and younger - are mis-prescribed. But if physicians are initiating thyroid hormone treatment without an appropriate indication, address THAT issue. Is it physician ignorance? Disagreement about what constitutes an appropriate indication?
Why assume that a wrong dose is always going to need to be reduced? Could not some be under-prescribed?
And not recognise that - while some might be willing to see if a dose reduction is beneficial - those deprescribed need to believe it will be reinstated if deprescribing has negative effects.
It is also entirely the patient's choice whether to accept the effects of thyroid hormone, whatever they are, or the effects of deprescribing. It is not any physician's right (and certainly not their duty) to deprescribe against the patient's wishes.
THEY blame us for being ignorant and not trusting our physicians. But they then publish this paper behind a paywall! Ignorance of this paper (and many others) is about control of access to information. Not about inherent ignorance, inability to understand, etc. Why should we trust anyone who enables this access control?
Physician-reported barriers and facilitators to thyroid hormone deprescribing in older adults
Brandon Moretti MD, Rachel Livecchi MD, Stephanie R. Taylor BS, Susan C. Pitt MD, Brittany L. Gay BS, Megan R. Haymart MD, Arti Bhan MD, Jennifer Perkins MD, Maria Papaleontiou MD
First published: 11 October 2024
The abstract of this manuscript was presented as a poster presentation at the 91st Annual Meeting of the American Thyroid Association in Montreal, Canada.
Abstract
Background
Thyroid hormone is one of the most commonly prescribed medications in the United States. Misuse of and overtreatment with thyroid hormone is common in older adults and can lead to cardiovascular and skeletal adverse events. Even though deprescribing can reduce inappropriate care, no studies have yet explored specific barriers and facilitators to guide thyroid hormone deprescribing in older adults (defined as discontinuation of thyroid hormone when initiated without an appropriate indication or dose reduction in those overtreated).
Methods
We conducted semi-structured interviews with 19 endocrinologists, geriatricians, and primary care physicians who prescribe thyroid hormone. Interviews were completed between July 2020 and December 2021 via two-way video conferencing. We used both an inductive and deductive content analysis guided by the Theoretical Domains Framework to evaluate transcribed and coded participant responses. Thematic analysis characterized themes related to barriers and facilitators to thyroid hormone deprescribing practices in older adults.
Results
The most commonly reported barriers to thyroid hormone deprescribing were related to patient-level factors, followed by physician- and system-level factors. Patient factors included patients' perceived need for thyroid hormone use and patient anxiety/concerns about potential side effects related to thyroid hormone dose reduction, patient lack of knowledge, and misinformation regarding deprescribing. Physician- and system-level barriers included clinic visit time constraints, physician inertia, physician lack of knowledge about deprescribing, perceived lack of sufficient patient follow-up, and electronic health record limitations. The most prominent physician-reported facilitators to thyroid hormone deprescribing were effective physician-to-patient communication, and positive physician–patient relationship, including patients' trust in their treating physician.
Conclusion
Barriers and facilitators to thyroid hormone deprescribing in older adults were reported at multiple levels including patient-, physician-, and system-level factors. Interventions to improve thyroid hormone deprescribing in older adults should aim to improve patient education and expectations, increase multidisciplinary physician awareness, and overcome physician inertia.
As usual, only this abstract is available without charge.